Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Ocean Biomedical, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 35 | 39 | +4 |
| Shares | 6.76M | 6.20M | −557.1K (−8.2%) |
| Value | $40.6M | $24.2M | −$16.4M (−40.4%) |
New holders (6)
Institutions that held Ocean Biomedical, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ayrton Capital LLC | 13,345 | $52.0K | 0.35% |
| Allspring Global Investments Holdings, LLC | 6,170 | $24.1K | 0.00% |
| Simplex Trading, LLC | 2,250 | $8.00K | 0.00% |
| Red Tortoise LLC | 358 | $1.40K | 0.00% |
| Nisa Investment Advisors, LLC | 30 | $117 | 0.00% |
| CWM, LLC | 63 | $0 | 0.00% |
Sold out (2)
Institutions that held Ocean Biomedical, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Virtu Financial LLC | 28,837 | $173.0K |
| State of Wisconsin Investment Board | 18,900 | $113.6K |